Biotech leaders converge in San Diego at Biocom CalAsia
By Helen Kaiao Chang
Thursday, June 18, 2009
Biocom, San Diego’s biotech industry organization, held its first CalAsia conference this week, with more than 300 attendees.
The event attracted a “who’s who” of biotech industry leaders from the Pacific Rim, and beyond.
Biocom plans to continue holding this as an annual event, said Joe Panetta, the group’s chief-executive officer. But it already had offers from at least one other country – South Korea – to jointly organize such events there.
Here’s a short introduction to some of the participants at the event. A complete directory of all the speakers is also attached.
San Diego & California
— Joe Panetta, CEO, Biocom, San Diego
— Ian Wisenberg, principal, Bio Global Consulting; former CFO of Biocom and original mastermind for the CalAsia conference, San Diego
— Gerald Yakatan, founder, Irisys; co-founder of HyberTek, considered the grandfather of San Diego’s high tech industry, San Diego
— Hui Cai, CEO, Inflexire BioPartners; Board chairperson of Sino-American Biomedical & Pharmaceutical Professionals Association, San Diego
— Mark Saad, CFO, Cytori Therapeutics, funded by Japanese and U.S. investors, San Diego
— Steven Mento, CEO, Conatus Pharmaceuticals, San Diego
—Ivor Royston
— Pamela Gardner, president, Biotech Vendor Services, San Diego
— James Zhu, attorney, Perkins Cole LLP, Los Angeles and Shanghai
China
— James Cai, chief representative, aTyr Pharma, Shanghai
India
— Anand Govindaluri, CEO, Go-Vin Holdings, Hyderabad
— Anula Jayasuriya, managing director, Evoluvence India Life Science Fund, New Delhi
South Korea
— Jong Hoon Choi, executive director, Korea Bio, a government’s biotech industry agency, Seoul
Australia
— Mario Pennisi, CEO, Queensland Clinical trials Network Inc, an industry group, Queensland
— Santo Santoro, Santo Santoro Consulting, Queensland
South Africa
— Bonginkosi Gamede, Portfolio manager, BioPAD, Pretoria
Complete directory and bios of speakers at CalAsia 2009
Whose Who in Pacific Biotech
Follow Helen on Twitter @HelenChang.
Leave your response!